Drug Choice Particularly Important In Medicare Population – Industry Study
Drug plans for the elderly should cover a wide range of drugs within each class, a study sponsored by the Pharmaceutical Research & Manufacturers of America concludes
You may also be interested in...
U.S. Pharmacopeia has relegated some of the pharmaceutical industry's biggest blockbuster drug "classes" to the status of "recommended subdivisions" in its draft model Medicare formulary
U.S. Pharmacopeia's draft model for Medicare prescription drug formularies establishes 146 unique therapeutic categories and pharmacologic classes, falling in between the numbers of drug groups sought by drug manufacturers and PBMs
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011